39
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1657440
Dunica develops therapies for early-stage type 1 diabetes to reduce insulin dependency.
About the Company
Dunica develops an oral-administered therapy aimed at reversing the progression of early-stage type 1 diabetes and reducing insulin dependency. The therapy utilizes a novel, immunomodulating phytochemical compound derived from a domesticated botanical strain. Designed for oral consumption, it enhances patient experience by eliminating the need for
injections. The formulation offers improved tissue permeability and a better safety profile with reduced risk of inflammation. Dunica has received research grants from pharmaceutical companies and is progressing towards clinical studies. The company's mission is to address the increasing global incidence of type 1 diabetes by providing a proactive treatment approach.
